Explore more press releases
Topics
Period
recent search
Showing: 1 – 05 of 238 Press Releases
12 March 2026
12 March 2026
Ipsen appoints Michelle C. Werner as EVP, President of North America
PARIS, FRANCE, 12 March 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Michelle C. Werner as Executive Vice President (EVP), President of North America, effective 23 March 2026. Michelle will serve on the Executive Leadership Team…
09 March 2026
09 March 2026
Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma
PARIS, FRANCE, 09 March 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik® (tazemetostat) in all indications from all Ipsen markets. Ipsen’s decision to withdraw is based on emerging data from the ongoing Phase Ib/III…
27 February 2026
27 February 2026
Ipsen receives positive CHMP opinion for Ojemda® for the treatment as monotherapy of children with relapsed or refractory BRAF-altered pediatric low-grade glioma
PARIS, FRANCE, 27 FEBRUARY 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the conditional marketing authorization of…
12 February 2026
12 February 2026
Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance
PARIS, FRANCE, 12 February 2026 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its financial results for the full year (FY) 2025 and for the fourth quarter of 2025.
29 January 2026
29 January 2026
Ipsen nominates Peter Guenter to its Board of Directors
PARIS, FRANCE, 29 January 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Peter Guenter to its Board as a Director, effective January 28, 2026, further to the vacancy of Mr. Henri Beaufour’s position.
Your dedicated contacts
Sally Bain
Head of Global Media Relations
Anne Liontas
France Media Relations